About Baymatob
Baymatob is a company based in Leichhardt (Australia) founded in 2017. Baymatob has raised $3.16 million across 2 funding rounds from investors including Australian Unity. Baymatob offers products and services including Oli PPH and AI-guided Solutions. Baymatob operates in a competitive market with competitors including sonio, Raydiant Oximetry, Janitri, HeraMED and OBMedical, among others.
- Headquarter Leichhardt, Australia
-
Sectors
HealthcareConsumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Baymatob Operations Pty. Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.16 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Baymatob
Baymatob offers a comprehensive portfolio of products and services, including Oli PPH and AI-guided Solutions.
Predicts postpartum hemorrhage risk to prevent maternal deaths.
Monitors pregnancy for complications and improves outcomes.
People of Baymatob
Unlock access to complete
Funding Insights of Baymatob
Baymatob has successfully raised a total of $3.16M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Baymatob
Baymatob has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Australian Unity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Retail banking services are provided to Australian customers.
|
Locked | Locked | Locked |
Investor details for Baymatob
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Baymatob
Investment portfolio details for Baymatob
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Baymatob
Detailed financials for Baymatob
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Baymatob Comparisons
Peer comparison for Baymatob
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Baymatob
Baymatob operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as sonio, Raydiant Oximetry, Janitri, HeraMED and OBMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based prenatal screening and diagnosis tool for radiology images
|
|
| Locked | Locked | Locked |
Wearable device for non-invasive fetal blood oxygen monitoring is offered.
|
|
| Locked | Locked | Locked |
Developer of medical-grade monitoring solutions for fetal, maternal, and newborn health
|
|
| Locked | Locked | Locked |
Smartphone-based devices for pregnancy monitoring are provided.
|
|
| Locked | Locked | Locked |
Fetal heart rate and contractions are monitored via wireless electrodes.
|
Detailed competitors of Baymatob
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Baymatob
Complete news archive for Baymatob
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baymatob
Baymatob was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Baymatob is headquartered in Leichhardt, Australia. It is registered at Leichhardt, New South Wales, Australia.
Tara Croft is the current CEO of Baymatob.
Baymatob is a funded company, having raised a total of $3.16M across 2 funding rounds to date.
Baymatob was founded in 2017 in Leichhardt, Australia, within the healthcare technology sector. Software has been developed to support AI-driven health risk analysis for professionals monitoring pregnant women. Key features encompass labor monitoring, postpartum hemorrhage risk prediction, and related assessments. Operations focus on tools that aid clinical decision-making in maternal health care.
Baymatob offers Oli PPH and AI-guided Solutions.
Baymatob has 1 investor. Key investors include Australian Unity.